secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astria Therapeutics, Inc. (—)
CIK:        0001454789
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0001104659-23-068331
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astria Therapeutics annual meeting results: share increase, charter amendment, director elections
--------------------------------------------------------------------------------

- Stockholders approved 4.3M share increase under 2015 Stock Incentive Plan.
- Stockholders approved charter amendment to expand director exculpation to certain senior officers.
- Board adopted amended and restated bylaws with updates for universal proxy rules and technical fixes.
- Elected Kenneth Bate, Joanne Beck, Hugh Cole as Class II directors for three-year terms.
- Ratified Ernst & Young as independent auditor for FY2023; advisory vote on executive compensation approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1454789/000110465923068331/0001104659-23-068331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1454789/000110465923068331/tm2317750d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-068331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer